Lobectomy has been the standard of care for patients with early stage non-small cell lung
cancer (NSCLC), resulting in nearly universal local control and excellent overall survival …

Objective For inoperable patients with pulmonary malignancy, stereotactic body
radiotherapy is a reasonable therapeutic option. Despite good early tumor control, local …

OBJECTIVE: We sought to compare the relative cost-effectiveness of surgical intervention
and stereotactic body radiation therapy in high risk patients with clinical stage I lung cancer …

OBJECTIVES: Stereotactic body radiotherapy (SBRT) is a novel form of noninvasive, highly
conformal radiation treatment that delivers a high dose to tumor. The advantage of the …

Background Lung cancer is the second most diagnosed cancer and the leading cause of
cancer-related mortality in Canada. Surgical resection is the treatment of choice for patients …

Pulmonary nodules are a common incidental finding on CT and the inexorable rise in the
use of CT (10% increase per year in the UK over the last decade) means that the frequency …

Stereotactic body radiotherapy (SBRT) represents a consolidated treatment option for
patients with medically inoperable early stage non-small cell lung cancer (NSCLC). The …

Background Stereotactic ablative body radiation therapy (SBRT) has evolved as the
standard treatment for patients with inoperable stage I non–small-cell lung cancer (NSCLC) …

Aim To study the dose-response of stage I non-small-cell lung cancer (NSCLC) in terms of
long-term local tumor control (LC) after conventional and hypofractionated photon …

Background Immunotherapy for lung cancer has been a hot research area for years. This
bibliometric analysis was intended to present research trends on melanoma …